| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.054 | 0.3 |